Skip to main content
Icelandic Medicines Agency Frontpage
Icelandic Medicines Agency Frontpage

Icelandic Medicines Agency

The sale of falsified dermal fillers for cosmetic use is prohibited

Substances, combinations of substances or items intended for facial or other dermal or mucous membrane filling by subcutaneous, submucous or intradermal injection or other introduction, excluding those for tattooing, fall within the definition of medical devices without an intended medical purpose.

Caution should be exercised when using these medical devices, and the purchase of falsified products should be avoided. The Icelandic Medicines Agency (IMA) highlights the following risks associated with buying falsified fillers.

  1. Manufacturing and transport conditions are not guaranteed to meet consumer requirements, and consequently the quality and safety of these products cannot be guaranteed.

  2. Hazardous substances or unverified sterilisation of products can lead to various complications, such as infections, allergic reactions, burns and other adverse effects.

  3. These products do not undergo conformity assessment, so competent authorities cannot guarantee their safety.

How can falsified products be avoided?

  1. Buy products directly from the manufacturer or its official distributor.

  2. Avoid responding to advertisements that are too good to be true.

  3. Check that the product bears the correct markings, particularly the CE marking and the notified body’s four-digit identification number below it.

  4. If there is any doubt about a product’s authenticity, send its batch number and expiry date to the manufacturer for verification.

Where can known or suspected falsified products be reported?

Known or suspected falsified products that fall within the definition of medical devices without an intended medical purpose can be reported to IMA by email at medical.devices@lyfjastofnun.is.

Further information on fillers for cosmetic use

Substances, combinations of substances or items injected under the skin for cosmetic filling are medical devices in the highest risk class, Class III. When placed on the market, they must have an EU declaration of conformity in which the manufacturer confirms that the devices meet the requirements of the Medical Devices Regulation. As these are Class III medical devices, a notified body must be identified in the EU declaration of conformity. The CE marking must appear on the medical device and its packaging. The notified body’s four-digit identification number must also appear alongside the CE marking on the packaging.

Last reviewed: 24th August 2022